Position in DGX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,204,087
+$117,378 QoQ
Shares Held
5,681
+2.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#462
of 1,088 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BAILARD, INC. holds $20,421,713 across 9 Diagnostics & Research names. DGX ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
66,702 | $12,705,396 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
6,041 | $3,028,715 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
3,995 | $2,103,127 | |
| 4 | DGX |
Quest Diagnostics Inc
This page
|
5,681 | $1,204,087 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
303 | $387,085 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,275 | $302,188 | |
| 7 | CDNA |
CareDx, Inc.
|
8,700 | $247,950 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
450 | $238,315 |
All Filings in DGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,204,087 | 5,681 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,086,709 | 5,545 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $702,102 | 4,046 | Shares | Sole | 2026-02-04 | |
| 2021-03-31 | $342,411 | 2,668 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,830,675 | 40,536 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $4,597,689 | 40,158 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,477,602 | 39,291 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,834,268 | 35,296 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||